Scientists test new Drug's safety with common pills
NCT ID NCT06948747
Summary
This early-stage study tested how a new drug, AZD5004, interacts with several common medications, including cholesterol drugs (like atorvastatin) and a diabetes drug (repaglinide). It also checked how an antibiotic (erythromycin) affects AZD5004. The goal was to see if taking AZD5004 changes how the body processes these other drugs, which is important for future safety. The study involved 49 healthy adult volunteers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Brooklyn, Maryland, 21225, United States
Conditions
Explore the condition pages connected to this study.